News articles about Vitamin Shoppe (NYSE:VSI) have been trending somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research group ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Vitamin Shoppe earned a coverage optimism score of 0.19 on Accern’s scale. Accern also assigned news coverage about the specialty retailer an impact score of 47.3302646153939 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
Vitamin Shoppe (NYSE VSI) opened at $4.35 on Tuesday. The stock has a market cap of $112.54, a price-to-earnings ratio of -0.40 and a beta of 0.64. Vitamin Shoppe has a fifty-two week low of $2.95 and a fifty-two week high of $20.70. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.36 and a current ratio of 2.25.
Vitamin Shoppe (NYSE:VSI) last released its earnings results on Tuesday, February 27th. The specialty retailer reported ($0.17) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.20) by $0.03. Vitamin Shoppe had a positive return on equity of 3.13% and a negative net margin of 21.39%. The company had revenue of $268.77 million for the quarter, compared to analysts’ expectations of $269.24 million. During the same period in the previous year, the business posted $0.36 EPS. The business’s revenue for the quarter was down 11.8% compared to the same quarter last year. sell-side analysts anticipate that Vitamin Shoppe will post -0.19 earnings per share for the current fiscal year.
In other news, major shareholder Vintage Capital Management Llc bought 133,804 shares of the business’s stock in a transaction on Tuesday, January 2nd. The stock was acquired at an average price of $4.28 per share, with a total value of $572,681.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Shah Capital Management bought 300,000 shares of the business’s stock in a transaction on Monday, February 5th. The stock was purchased at an average cost of $3.83 per share, with a total value of $1,149,000.00. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 1,000,639 shares of company stock worth $4,387,647. Company insiders own 1.07% of the company’s stock.
WARNING: This piece of content was originally published by BBNS and is the property of of BBNS. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://baseballnewssource.com/2018/03/20/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-vitamin-shoppe-vsi-share-price/1963417.html.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.